Table of Contents Author Guidelines Submit a Manuscript
Neural Plasticity
Volume 2017, Article ID 4153076, 16 pages
https://doi.org/10.1155/2017/4153076
Research Article

Mechanisms and Consequences of Dopamine Depletion-Induced Attenuation of the Spinophilin/Neurofilament Medium Interaction

1Department of Biology, Indiana University-Purdue University Indianapolis, 723 W. Michigan St., Indianapolis, IN 46202, USA
2Department of Chemistry and Chemical Biology, Indiana University-Purdue University Indianapolis, 723 W. Michigan St., Indianapolis, IN 46202, USA
3Neuroscience Undergraduate Program, Indiana University-Purdue University Indianapolis, 723 W. Michigan St., Indianapolis, IN 46202, USA
4Department of Psychology, Indiana University-Purdue University Indianapolis, 723 W. Michigan St., Indianapolis, IN 46202, USA
5Molecular Physiology and Biophysics, Vanderbilt University School of Medicine University, 724 Robinson Research Building, 23rd Ave South at Pierce, Nashville, TN 37232, USA
6Department of Biochemistry and the Mass Spectrometry Research Center, Vanderbilt University School of Medicine University, 465 21st Ave S. Room 9160, MRB III, Nashville, TN 37232, USA
7Stark Neurosciences Research Institute, Indiana University School of Medicine, Indiana, IN, USA

Correspondence should be addressed to Anthony J. Baucum II; ude.iupui@mucuabja

Received 9 January 2017; Accepted 16 February 2017; Published 28 May 2017

Academic Editor: Tomasz Wójtowicz

Copyright © 2017 Andrew C. Hiday et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Calabresi, R. Maj, A. Pisani, N. B. Mercuri, and G. Bernardi, “Long-term synaptic depression in the striatum: physiological and pharmacological characterization,” The Journal of Neuroscience, vol. 12, no. 11, pp. 4224–4233, 1992. View at Google Scholar
  2. C. A. Ingham, S. H. Hood, and G. W. Arbuthnott, “Spine density on neostriatal neurones changes with 6-hydroxydopamine lesions and with age,” Brain Research, vol. 503, no. 2, pp. 334–338, 1989. View at Publisher · View at Google Scholar · View at Scopus
  3. C. A. Ingham, S. H. Hood, B. van Maldegem, A. Weenink, and G. W. Arbuthnott, “Morphological changes in the rat neostriatum after unilateral 6-hydroxydopamine injections into the nigrostriatal pathway,” Experimental Brain Research, vol. 93, no. 1, pp. 17–27, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Stephens, A. J. Mueller, A. F. Shering et al., “Evidence of a breakdown of corticostriatal connections in Parkinson’s disease,” Neuroscience, vol. 132, no. 3, pp. 741–754, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. R. M. Villalba, H. Lee, and Y. Smith, “Dopaminergic denervation and spine loss in the striatum of MPTP-treated monkeys,” Experimental Neurology, vol. 215, no. 2, pp. 220–227, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Calabresi, N. B. Mercuri, G. Sancesario, and G. Bernardi, “Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson’s disease,” Brain, vol. 116, Part 2, pp. 433–452, 1993. View at Google Scholar
  7. B. Picconi, V. Ghiglieri, V. Bagetta, I. Barone, C. Sgobio, and P. Calabresi, “Striatal synaptic changes in experimental parkinsonism: role of NMDA receptor trafficking in PSD,” Parkinsonism & Related Disorders, vol. 14, Supplement 2, pp. S145–S149, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. A. M. Brown, A. J. Baucum, M. A. Bass, and R. J. Colbran, “Association of protein phosphatase 1 gamma 1 with spinophilin suppresses phosphatase activity in a Parkinson disease model,” The Journal of Biological Chemistry, vol. 283, no. 21, pp. 14286–14294, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. A. M. Brown, A. Y. Deutch, and R. J. Colbran, “Dopamine depletion alters phosphorylation of striatal proteins in a model of parkinsonism,” The European Journal of Neuroscience, vol. 22, no. 1, pp. 247–256, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Picconi, F. Gardoni, D. Centonze et al., “Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism,” The Journal of Neuroscience, vol. 24, no. 23, pp. 5283–5291, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. P. T. Cohen, “Protein phosphatase 1—targeted in many directions,” Journal of Cell Science, vol. 115, Part 2, pp. 241–256, 2002. View at Google Scholar
  12. T. D. Hurley, J. Yang, L. Zhang et al., “Structural basis for regulation of protein phosphatase 1 by inhibitor-2,” The Journal of Biological Chemistry, vol. 282, no. 39, pp. 28874–28883, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. M. J. Ragusa, B. Dancheck, D. A. Critton, A. C. Nairn, R. Page, and W. Peti, “Spinophilin directs protein phosphatase 1 specificity by blocking substrate binding sites,” Nature Structural & Molecular Biology, vol. 17, no. 4, pp. 459–464, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. R. J. Colbran, M. A. Bass, R. B. McNeill et al., “Association of brain protein phosphatase 1 with cytoskeletal targeting/regulatory subunits,” Journal of Neurochemistry, vol. 69, no. 3, pp. 920–929, 1997. View at Google Scholar
  15. P. B. Allen, C. C. Ouimet, and P. Greengard, “Spinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 18, pp. 9956–9961, 1997. View at Google Scholar
  16. Z. Yan, L. Hsieh-Wilson, J. Feng et al., “Protein phosphatase 1 modulation of neostriatal AMPA channels: regulation by DARPP-32 and spinophilin,” Nature Neuroscience, vol. 2, no. 1, pp. 13–17, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. P. B. Allen, V. Zachariou, P. Svenningsson et al., “Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity,” Neuroscience, vol. 140, no. 3, pp. 897–911, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. M. D. Li, T. C. Burns, A. A. Morgan, and P. Khatri, “Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases,” Acta Neuropathologica Communications, vol. 2, no. 1, p. 93, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. A. J. Baucum 2nd, N. Jalan-Sakrikar, Y. Jiao et al., “Identification and validation of novel spinophilin-associated proteins in rodent striatum using an enhanced ex vivo shotgun proteomics approach,” Molecular & Cellular Proteomics, vol. 9, no. 6, pp. 1243–1259, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Yuan, H. Sershen, Veeranna et al., “Neurofilament subunits are integral components of synapses and modulate neurotransmission and behavior in vivo,” Molecular Psychiatry, vol. 20, no. 8, pp. 986–994, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Strack, R. S. Westphal, R. J. Colbran, F. F. Ebner, and B. E. Wadzinski, “Protein serine/threonine phosphatase 1 and 2A associate with and dephosphorylate neurofilaments,” Brain Research. Molecular Brain Research, vol. 49, no. 1-2, pp. 15–28, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. C. M. Johannessen, J. S. Boehm, S. Y. Kim et al., “COT drives resistance to RAF inhibition through MAP kinase pathway reactivation,” Nature, vol. 468, no. 7326, pp. 968–972, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. A. J. Baucum, B. C. Shonesy, K. L. Rose, and R. J. Colbran, “Quantitative proteomics analysis of CaMKII phosphorylation and the CaMKII interactome in the mouse forebrain,” ACS Chemical Neuroscience, vol. 6, no. 4, pp. 615–631, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. R. M. Gustin, B. C. Shonesy, S. L. Robinson et al., “Loss of Thr286 phosphorylation disrupts synaptic CaMKIIα targeting, NMDAR activity and behavior in pre-adolescent mice,” Molecular and Cellular Neurosciences, vol. 47, no. 4, pp. 286–292, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. T. A. Wills, A. J. Baucum 2nd, K. M. Holleran et al., “Chronic intermittent alcohol disrupts the GluN2B-associated proteome and specifically regulates group I mGlu receptor-dependent long-term depression,” Addiction Biology, vol. 22, no. 2, pp. 275–290, 2017. View at Publisher · View at Google Scholar · View at Scopus
  26. A. J. Baucum 2nd, A. M. Brown, and R. J. Colbran, “Differential association of postsynaptic signaling protein complexes in striatum and hippocampus,” Journal of Neurochemistry, vol. 124, no. 4, pp. 490–501, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Szklarczyk, A. Franceschini, S. Wyder et al., “STRING v10: protein-protein interaction networks, integrated over the tree of life,” Nucleic Acids Research, vol. 43, no. Database issue, pp. D447–D452, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. R. T. Terry-Lorenzo, L. C. Carmody, J. W. Voltz et al., “The neuronal actin-binding proteins, neurabin I and neurabin II, recruit specific isoforms of protein phosphatase-1 catalytic subunits,” The Journal of Biological Chemistry, vol. 277, no. 31, pp. 27716–27724, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. R. T. Terry-Lorenzo, E. Elliot, D. C. Weiser, T. D. Prickett, D. L. Brautigan, and S. Shenolikar, “Neurabins recruit protein phosphatase-1 and inhibitor-2 to the actin cytoskeleton,” The Journal of Biological Chemistry, vol. 277, no. 48, pp. 46535–46543, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. R. T. Terry-Lorenzo, M. Inoue, J. H. Connor et al., “Neurofilament-L is a protein phosphatase-1-binding protein associated with neuronal plasma membrane and post-synaptic density,” The Journal of Biological Chemistry, vol. 275, no. 4, pp. 2439–2446, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. S. D. Grossman, M. Futter, G. L. Snyder et al., “Spinophilin is phosphorylated by Ca2+/calmodulin-dependent protein kinase II resulting in regulation of its binding to F-actin,” Journal of Neurochemistry, vol. 90, no. 2, pp. 317–324, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. L. C. Hsieh-Wilson, F. Benfenati, G. L. Snyder, P. B. Allen, A. C. Nairn, and P. Greengard, “Phosphorylation of spinophilin modulates its interaction with actin filaments,” The Journal of Biological Chemistry, vol. 278, no. 2, pp. 1186–1194, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Xu, Y. Chen, R. Lu, C. Cottingham, K. Jiao, and Q. Wang, “Protein kinase A phosphorylation of spinophilin modulates its interaction with the alpha 2A-adrenergic receptor (AR) and alters temporal properties of alpha 2AAR internalization,” The Journal of Biological Chemistry, vol. 283, no. 21, pp. 14516–14523, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. G. H. Iyer, M. J. Moore, and S. S. Taylor, “Consequences of lysine 72 mutation on the phosphorylation and activation state of cAMP-dependent kinase,” The Journal of Biological Chemistry, vol. 280, no. 10, pp. 8800–8807, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. P. D. Smith, M. P. Mount, R. Shree et al., “Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2,” The Journal of Neuroscience, vol. 26, no. 2, pp. 440–447, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Yamamura, R. Morigaki, J. Kasahara et al., “Dopamine signaling negatively regulates striatal phosphorylation of Cdk5 at tyrosine 15 in mice,” Frontiers in Cellular Neuroscience, vol. 7, p. 12, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. J. C. Evans, C. M. Robinson, M. Shi, and D. J. Webb, “The guanine nucleotide exchange factor (GEF) Asef2 promotes dendritic spine formation via Rac activation and spinophilin-dependent targeting,” The Journal of Biological Chemistry, vol. 290, no. 16, pp. 10295–10308, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Feng, Z. Yan, A. Ferreira et al., “Spinophilin regulates the formation and function of dendritic spines,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 16, pp. 9287–9292, 2000. View at Google Scholar
  39. A. R. Di Sebastino, S. Fahim, H. A. Dunn et al., “Role of spinophilin in group I metabotropic glutamate receptor endocytosis, signaling and synaptic plasticity,” The Journal of Biological Chemistry, vol. 291, no. 34, pp. 17602–17615, 2016. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Hu, M. Vidovic, M. M. Chen, Q. Y. Lu, and Z. M. Song, “Activation of alpha 2A adrenoceptors alters dendritic spine development and the expression of spinophilin in cultured cortical neurones,” Brain Research, vol. 1199, pp. 37–45, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. A. J. Baucum 2nd, S. Strack, and R. J. Colbran, “Age-dependent targeting of protein phosphatase 1 to Ca2+/calmodulin-dependent protein kinase II by spinophilin in mouse striatum,” PLoS One, vol. 7, no. 2, article e31554, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. D. Sarrouilhe, A. di Tommaso, T. Metaye, and V. Ladeveze, “Spinophilin: from partners to functions,” Biochimie, vol. 88, no. 9, pp. 1099–1113, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Futter, K. Uematsu, S. A. Bullock et al., “Phosphorylation of spinophilin by ERK and cyclin-dependent PK 5 (Cdk5),” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 9, pp. 3489–3494, 2005. View at Google Scholar
  44. K. E. Cleverley, J. C. Betts, W. P. Blackstock, J. M. Gallo, and B. H. Anderton, “Identification of novel in vitro PKA phosphorylation sites on the low and middle molecular mass neurofilament subunits by mass spectrometry,” Biochemistry, vol. 37, no. 11, pp. 3917–3930, 1998. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Al-Chalabi and C. C. Miller, “Neurofilaments and neurological disease,” BioEssays, vol. 25, no. 4, pp. 346–355, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. J. P. Gou, T. Gotow, P. A. Janmey, and J. F. Leterrier, “Regulation of neurofilament interactions in vitro by natural and synthetic polypeptides sharing Lys-Ser-Pro sequences with the heavy neurofilament subunit NF-H: neurofilament crossbridging by antiparallel sidearm overlapping,” Medical & Biological Engineering & Computing, vol. 36, no. 3, pp. 371–387, 1998. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Trimpin, A. E. Mixon, M. D. Stapels, M. Y. Kim, P. S. Spencer, and M. L. Deinzer, “Identification of endogenous phosphorylation sites of bovine medium and low molecular weight neurofilament proteins by tandem mass spectrometry,” Biochemistry, vol. 43, no. 7, pp. 2091–2105, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. O. J. Kim, M. A. Ariano, R. A. Lazzarini, M. S. Levine, and D. R. Sibley, “Neurofilament-M interacts with the D1 dopamine receptor to regulate cell surface expression and desensitization,” The Journal of Neuroscience, vol. 22, no. 14, pp. 5920–5930, 2002. View at Publisher · View at Google Scholar
  49. M. Ferrer-Alcon, R. La Harpe, J. Guimon, and J. A. Garcia-Sevilla, “Downregulation of neuronal cdk5/p35 in opioid addicts and opiate-treated rats: relation to neurofilament phosphorylation,” Neuropsychopharmacology, vol. 28, no. 5, pp. 947–955, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. H. R. Fuller, M. L. Hurtado, T. M. Wishart, and M. A. Gates, “The rat striatum responds to nigro-striatal degeneration via the increased expression of proteins associated with growth and regeneration of neuronal circuitry,” Proteome Science, vol. 12, no. 1, p. 20, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Sharma, P. Sharma, and H. C. Pant, “CDK-5-mediated neurofilament phosphorylation in SHSY5Y human neuroblastoma cells,” Journal of Neurochemistry, vol. 73, no. 1, pp. 79–86, 1999. View at Google Scholar
  52. M. Day, Z. Wang, J. Ding et al., “Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models,” Nature Neuroscience, vol. 9, no. 2, pp. 251–259, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Day, D. Wokosin, J. L. Plotkin, X. Tian, and D. J. Surmeier, “Differential excitability and modulation of striatal medium spiny neuron dendrites,” The Journal of Neuroscience, vol. 28, no. 45, pp. 11603–11614, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Zaja-Milatovic, D. Milatovic, A. M. Schantz et al., “Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease,” Neurology, vol. 64, no. 3, pp. 545–547, 2005. View at Publisher · View at Google Scholar
  55. R. M. Villalba and Y. Smith, “Differential striatal spine pathology in Parkinson’s disease and cocaine addiction: a key role of dopamine?” Neuroscience, vol. 251, pp. 2–20, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. H. S. Bateup, P. Svenningsson, M. Kuroiwa et al., “Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs,” Nature Neuroscience, vol. 11, no. 8, pp. 932–939, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. J. P. Doyle, J. D. Dougherty, M. Heiman et al., “Application of a translational profiling approach for the comparative analysis of CNS cell types,” Cell, vol. 135, no. 4, pp. 749–762, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Heiman, A. Schaefer, S. Gong et al., “A translational profiling approach for the molecular characterization of CNS cell types,” Cell, vol. 135, no. 4, pp. 738–748, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. K. T. Rigbolt, T. A. Prokhorova, V. Akimov et al., “System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation,” Science Signaling, vol. 4, no. 164, article rs3, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. P. Rudrabhatla, P. Grant, H. Jaffe, M. J. Strong, and H. C. Pant, “Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF-M/H) in Alzheimer’s disease by iTRAQ,” The FASEB Journal, vol. 24, no. 11, pp. 4396–4407, 2010. View at Publisher · View at Google Scholar · View at Scopus